Vivek Y. Reddy, MD is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai.
Medical University of South Carolina
Dr. Sheldon E. Litwin is the Alicia Spaulding-Paolozzi Professor of Cardiology and Director of Cardiac Imaging at the Medical University of South Carolina.
Dr. Litwin is nationally recognized for his expertise in advanced cardiac imaging and its use in the diagnosis of heart disease and treatment of patients with heart disease. He has been involved in multiple clinical trials using new therapies for heart failure with preserved ejection fraction (HFpEF).
Dr. Borlaug is Professor of Medicine and Director, Circulatory Failure Research for the Division of Cardiovascular Diseases, and Chair for Research for the Division of Circulatory Failure in the Department of Cardiovascular Medicine at the Mayo Clinic, Rochester, Minnesota.
Dr. Borlaug’s research interests focus on the pathophysiology, diagnosis and treatment of heart failure, particularly heart failure with preserved ejection fraction, with an emphasis on hemodynamics.
Dr. Marat Fudim is Assistant Professor of Medicine at Duke University and member of the Duke Clinical Research Institute He currently serves as the Medical Director for the Heart Failure Research Unit and Heart Failure Remote Monitoring.
Dr. Fudim’s research interest is in the pathophysiology of HF, device investigation and neuromodulation. In 2021, he was awarded the Douglas Zipes Distinguished Young Investigator Award for his work in using Splanchnic Nerve Blockade to Manage Heart Failure.
FAHA, FACC, FASE
Dr. Shah is the Stone Endowed Professor of Medicine and Director of Research for the Bluhm Cardiovascular Institute at Northwestern University Feinberg School of Medicine. Dr. Shah is also Director of the Center for Deep Phenotyping and Precision Therapeutics in the Institute or Augmented Intelligence in Medicine at Northwestern University, and he is Director of the Heart Failure with Preserved Ejection Fraction (HFpEF) Program at Northwestern Memorial Hospital in Chicago, Illinois, USA.
Dr. Shah’s research is focused on improving our understanding of the epidemiology, mechanisms, and treatment of HFpEF. Dr. Shah started the first dedicated HFpEF clinical program in the world at Northwestern University in 2007 and has been a leading enroller in clinical trials for HFpEF since that time.
Dr. Levin is a Heart Failure Cardiologist by training and a veteran in the field of biomedical engineering and cardiology.
As co-founder of Coridea, his inventions and co-inventions have successfully launched companies including Ardian (Medtronic), CHF Solutions (Gambro), Respicardia (formerly, Cardiac Concepts), eValve (Abbott) and RenalGuard/Reprieve Cardiovascular (PLC Medical), Cibiem and Soffio Medical. He has held a number of positions in these companies including President, Chief Scientific Officer, Chief Medical Officer and VP of R&D.
The Axon™ Ablation System is an investigational device and is not currently approved for clinical use in any geography.
CAUTION – Investigational Device. Limited by Federal (or United States) law to Investigational Use.
©2022 Axon Therapies Inc. All rights reserved. Axon™ is a trademark of Axon Therapies, Inc.